The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dedicated overseas consultation for patients evacuated from the south Pacific: Report of experience after six months of existence.
 
Nicolas Epaillard
No Relationships to Disclose
 
Arthur Geraud
Employment - Drug Impairment Training for Educational Professionals (DITEP)
Consulting or Advisory Role - Hengrui Therapeutics
Research Funding - Drug Impairment Training for Educational Professionals (DITEP)
Travel, Accommodations, Expenses - AstraZeneca; Novartis
 
Gabriel Garcia
No Relationships to Disclose
 
Ronan Flippot
Honoraria - Astellas Pharma; Bristol-Myers Squibb; IPSEN; MSD Oncology; Pfizer
Consulting or Advisory Role - Ipsen; Janssen Oncology
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Bayer; Merck/Pfizer; Merck/Pfizer
 
Laury Cherot
No Relationships to Disclose
 
Benjamin Besse
Research Funding - Abbvie (Inst); Amgen (Inst); Aptitude Health (Inst); AstraZeneca (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Ellipses Pharma (Inst); Genmab (Inst); Genzyme (Inst); Genzyme (Inst); Hedera Dx (Inst); Inivata (Inst); Ipsen (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); PharmaMar (Inst); Roche/Genentech (Inst); Sanofi (Inst); socar (Inst); Taiho Pharmaceutical (Inst); Turning Point Therapeutics (Inst)
 
Felix Blanc-Durand
Honoraria - Cureety
Consulting or Advisory Role - AstraZeneca/Merck (Inst); Eisai/MSD; GlaxoSmithKline (Inst)
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; GlaxoSmithKline
 
Kaissa Ouali
Consulting or Advisory Role - Sotio
Travel, Accommodations, Expenses - Amgen; Sotio
 
Linda Mahjoubi
No Relationships to Disclose
 
Emilie Routier
No Relationships to Disclose
 
Gianmaria Drovetti
No Relationships to Disclose
 
Pierre Gustin
No Relationships to Disclose
 
Margarida Matias
No Relationships to Disclose
 
Jean François Moulin
No Relationships to Disclose
 
Simon Azan
No Relationships to Disclose
 
Robert Herve
No Relationships to Disclose
 
Barbara Pistilli
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/UCB Japan; Myriad Genetics; Novartis; PIERRE FABRE; Puma Biotechnology
Research Funding - AstraZeneca (Inst); DAIICHI-SANKYO (Inst); Gilead Sciences (Inst); Merus (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; MSD Oncology; Novartis; Pfizer; Pierre Fabre
 
Emeline Colomba
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Ipsen; Merck
Consulting or Advisory Role - BMS Brazil; GlaxoSmithKline; Ipsen; Pfizer; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Pfizer
 
Michel Pierre Ducreux
Employment - Sandoz (I)
Honoraria - Bayer; Pierre Fabre; Roche/Genentech; TERUMO
Consulting or Advisory Role - Amgen; AstraZeneca; Basilea; Bayer; Daiichi Sankyo/Astra Zeneca; GlaxoSmithKline; HalioDx; Ipsen; Lilly; Merck Serono; MSD; Novartis; Pierre Fabre; Rafael Pharmaceuticals; Roche; Servier; Sotio; Zymeworks
Speakers' Bureau - Amgen; AstraZeneca; Bayer; GlaxoSmithKline; HalioDx; Lilly; Merck KGaA; MSD; Pierre Fabre; Roche; SERVIER
Research Funding - Keocyt (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; Merck Serono; Pierre Fabre; Roche; SERVIER
 
Charles Honoré
No Relationships to Disclose